ArticleJACC. Advances2024
The Science of Precision Prevention: Research Opportunities and Clinical Applications to Reduce Cardiovascular Health Disparities.
Article in JACC. Advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
41 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Use of artificial intelligence in predicting in-hospital cardiac and respiratory arrest in an acute care environment-implications for clinical practice.Frontiers in medical technology · 2025Pooled it
- Precision Prevention for Health: The Global Alliance Framework for the Promotion of Physical Activity.Sports medicine (Auckland, N.Z.) · 2026Article
- Implications of the new US AI framework in medicine.Communications medicine · 2026Article
- Evidence, use cases, and implementation safeguards of large language models in primary care.Communications medicine · 2026Review
- Identifying and mitigating bias in multiple aspects of modern clinical research.Communications medicine · 2026Review
- Applying the 5P framework to improve cancer prevention in European health systems.Journal of public health policy · 2026Article
- Relationship between culprit lesion high-risk plaque features and adverse cardiovascular outcome at two years follow-up in patients with acute coronary syndrome. Insights from the OPTICO-ACS study.The international journal of cardiovascular imaging · 2026Observational
- Detecting and Mitigating Bias for Inclusive and Trustworthy Clinical Research: A Scientific Statement From the American Heart Association.Circulation. Genomic and precision medicine · 2026Review
- Impact of the mindfulness-based blood pressure reduction (MB-BP) program on cardiovascular health: A randomized clinical trial.American journal of preventive cardiology · 2026Article
- Artificial intelligence electrocardiography for left ventricular systolic dysfunction demonstrates preserved performance across demographic training imbalances.European heart journal. Digital health · 2026Article
- Development of a school program for vaping and smoking prevention and protocol for a cluster randomized controlled trial in fifth grade students.Scientific reports · 2026Article
- Personalized artificial intelligence based left ventricular ejection fraction and systolic dysfunction assessment.NPJ digital medicine · 2026Article
- The global cardiovascular-liver-metabolic syndemic: epidemiology, trends and challenges.Nature reviews. Cardiology · 2026Review
- Total product lifecycle regulatory considerations and recommendations for generative AI-enabled medical devices.European heart journal. Digital health · 2026Article
- Obesity and Beyond: Lifestyle Patterns and Cardiometabolic Burden in High-Risk Patients with Coronary Artery Disease-Moving Toward Personalized Prevention.Diseases (Basel, Switzerland) · 2026Article
- Do world-wide policy initiatives for regulating health care related artificial intelligence safeguard the declaration of Helsinki?EClinicalMedicine · 2026Review
- Access to digital health technologies: personalized framework and global perspectives.Nature reviews. Cardiology · 2026Review
- Precision cardiovascular medicine: global imperative for equity through innovation.Frontiers in cardiovascular medicine · 2026Article
- From remote screening to precision prevention: responsible multimodal AI for risk prediction and equitable oral healthcare.Frontiers in oral health · 2026Review
- Redefining cardiometabolic biomarkers in the big data era: toward a personalized medicine-centered reconstruction of risk prediction models.Frontiers in cardiovascular medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
28 authors.
Funding
Abstract
Precision prevention embraces personalized prevention but includes broader factors such as social determinants of health to improve cardiovascular health. The quality, quantity, precision, and diversity of data relatable to individuals and communities continue to expand. New analytical methods can be applied to these data to create tools to attribute risk, which may allow a better understanding of cardiovascular health disparities. Interventions using these analytic tools should be evaluated to establish feasibility and efficacy for addressing cardiovascular disease disparities in diverse individuals and communities. Training in these approaches is important to create the next generation of scientists and practitioners in precision prevention. This state-of-the-art review is based on a workshop convened to identify current gaps in knowledge and methods used in precision prevention intervention research, discuss opportunities to expand trials of implementation science to close the health equity gaps, and expand the education and training of a diverse precision prevention workforce.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.